Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains

A top broker forecasts more outperformance from this dividend paying ASX tech stock.

The All Ordinaries Index (ASX: XAO) has gained 2.6% in 12 months, with plenty of lifting help from this rocketing ASX All Ords tech stock.

The surging ASX share in question is SKS Technologies Group Ltd (ASX: SKS).

If you're not familiar with SKS, the company designs and installs electrical, audiovisual and communications networking systems into the data centre, government and corporate sectors. And it's been catching sustained tailwinds from the AI revolution.

In afternoon trade on Wednesday, SKS shares were up 6.5% for the day, changing hands for $9.23 apiece.

That sees shares in the ASX All Ords tech stock up a jaw dropping 249.6% since 12 August 2025, when you could have picked up shares for a mere $2.64 each.

Or enough to turn a $10,000 investment into $34,962. In one year!

And, adding a little icing to this very profitable cake, SKS shares trade on a fully franked 0.9% trailing dividend yield.

Here's what's been spurring investor interest.

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today

Image source: Getty Images

Why are SKS shares racing higher?

For some insight into why SKS shares have been skyrocketing, you need look no further than SKS Technologies' 3 August trade update.

The ASX All Ords tech stock reported that it now expects to achieve an unaudited before-tax profit of $39.3 million. That's up 15.6% from the $34 million profit guidance the company reported in February, supported by improved margins.

Unaudited revenue of $347.9 million was up 2.3% from prior guidance of $340 million.

"The significant increase in profitability reflects the continued strength of our business and the disciplined execution of our strategy over recent years," SKS Technologies CEO Matthew Jinks said.

Top broker forecasts more upside for the surging ASX All Ords tech stock

Following the update, Canaccord Genuity released a bullish noted on its outlook for SKS Technologies.

According to the broker:

The key read-through is the margin uplift: FY26 PBT margin of 11.3% is ~130bps above the 10% previously guided, and with a strong 2H margin of 12.3%. The upside was driven overwhelmingly by margin/operating leverage rather than top-line, underscoring the benefits of scale and continuity of work allowing for the conversion of revenue to profit at an increasing rate.

Looking ahead, Canaccord added:

Going into FY27, we expect further scale benefits and see the 2H margin of +12% as maintainable even when accounting for the fact that each additional staff member could be less efficient than their current staff base. We also think SKS realises genuine efficiency benefits as contracts scale, which should limit margins retracting and instead provide upside potential to our estimates over time.

Connecting the dots, Canaccord maintained its buy rating on the ASX All Ords tech stock and increased its price target to $10.30 a share (up from the prior $9.05 a share).

At the recent SKS share price, that represents a further potential upside of more than 11%, not including those upcoming dividends.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sks Technologies Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »